Pre-market Hot Trades in US Stocks
Oriental Rise, down 7.41% in pre-market trading, has no significant news recently. The trading is active with clear capital flow, and considering the sector and industry trends, the stock shows significant volatility, with specific reasons needing further observation.
Oklo is up 3.01% in pre-market trading. Based on recent key news:
<ol>
<li>
On January 15, Oklo signed an agreement with Meta to develop a 1.2GW power plant in Ohio to support Meta's data center operations, driving the stock price up by 17%. This move has boosted market confidence in Oklo, with the stock continuing to rise by 3.01% in pre-market trading. Source: MarketBeat
</li>
<li>
On January 14, Oklo's founder and COO sold over $10 million worth of stock, raising concerns about internal confidence in the company. This news may exert short-term pressure on the stock price. Source: SEC filings
</li>
<li>
On January 14, analysts maintained a hold rating on Oklo, not including it in the recommended buy list. Analysts believe that five other stocks offer better investment value, which may affect investor interest in Oklo. Source: MarketBeat The nuclear industry has seen increased attention recently, with market volatility intensifying.
</li>
</ol>
Top Gainers in Pre-market US Stocks
Venus Concept is up 132.17% in pre-market trading, with no significant news recently. The trading is active with clear capital flow, and considering the sector and industry trends, the stock shows significant volatility, with specific reasons needing further observation.
Baiya is up 54.32% in pre-market trading. There is no significant news recently; the trading is active with clear capital flow, and considering the sector and industry trends, the stock shows significant volatility, with specific reasons needing further observation. no_news
Jaguar Health is up 25.11% in pre-market trading. Based on recent key news:
<ol>
<li>
On January 15, Jaguar Health signed a licensing agreement with Woodward Specialty LLC, where Woodward will pay Napo $18 million, with $16 million paid on the effective date of the agreement. This news has driven the stock price up. Source: SEC filings
</li>
<li>
On January 14, Jaguar Health updated recent catalysts at the Lytham Partners Healthcare Investor Summit, with CEO Lisa Conte giving a virtual presentation, leading to market optimism about the company's future development. Source: ACCESS Newswire
</li>
<li>
On January 12, Jaguar Health signed a manufacturing and supply agreement with Woodward Specialty to ensure the commercial supply of Mytesi in the United States. This move is seen as part of the company's strategic expansion. Source: SEC filings Recent policy changes in the pharmaceutical industry have had significant impacts
</li>
</ol>

ORIS

OKLO

Oriental Rise pre-market down 7.41%; Oklo pre-market up 3.01%; Venus Concept pre-market up 132.17%; Baiya pre-market up 54.32%; Jaguar Health pre-market up 25.11%

Pre-market hot trades in US stocks: Oriental Rise pre-market down 7.41%; Oklo pre-market up 3.01%